The Leuprolide Acetate Suspension Fo, cataloged under National Stock Number 6505-01-506-2039, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbvie Us Llc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-506-2039 |
| Primary Part Number | NDC00074-3641-03 |
| Item Name | Leuprolide Acetate Suspension Fo |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbvie Us Llc |
| Status | ACTIVE |
| American Hospital Formulary Service Classification Number | 100000 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC00074-3641-03 PRIMARY | Abbvie Us Llc (USA) |
| Reference | Meaning |
|---|---|
| 03-0084 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM030033 | 5/1 Secondary reference Defense Medical Standardization Board |
| NDC00074-3641-03 | 3/9 Design control — primary reference Abbott Laboratories Diagnostics Div |
NSN 6505-01-506-2039 is a Leuprolide Acetate Suspension Fo, manufactured by Abbvie Us Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-506-2039 has 1 manufacturer part number on file: NDC00074-3641-03 (Abbvie Us Llc).
1 possible match (shared part number, not a government interchangeability claim): 4130-01-535-3511. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00074-3641-03: Special Features: EACH SYRINGE CONTAINS STERILE LYOPHILIZED MICROSPHERES. WHEN MIXED WITH DILUENT BECOMES A SUSPENSION INTENDED AS A SINGLE MONTHLY INTRAMUSCULAR INJECTION. THE FRONT CHAMBER IS 3.75 MG LEUPROLIDE ACETATE, THE SECOND CHAMBER CONTAINS DILUENT; PREFILLED DUAL CHAMBER SYRINGE; PRESERVATIVE FREE; SINGLE USE, STORE AT 25 DEG C; FOR MANAGEMENT OF ENDOMETRIOSIS DEGC; Part Name Assigned by Controlling Agency: LEUPROLIDE ACETATE SUSPENSION FOR INJECTION PREFILLED SYRINGE 3.75MG MONTH/SINGLE USE; American Hospital Formulary Service Classification Number: 100000. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.